Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Dec;22(6):677–683. doi: 10.1111/j.1365-2125.1986.tb02957.x

The influence of quinolone derivatives on theophylline clearance.

W J Wijnands, T B Vree, C L van Herwaarden
PMCID: PMC1401213  PMID: 3567014

Abstract

Enoxacin decreases the metabolic clearance of the bronchodilator theophylline not only in severely ill patients, but also in patients with stable chronic obstructive airways disease. In this comparative study, significantly increased plasma theophylline concentrations were measured during co-administration of enoxacin (110.9%) and, to a lesser degree, also during co-administration of pefloxacin (19.6%) and ciprofloxacin (22.8%). Total body clearance of theophylline was significantly decreased by enoxacin (63.6%), ciprofloxacin (30.4%) and pefloxacin (29.4%). The pharmacokinetic parameters of theophylline did not change during co-administration of ofloxacin and nalidixic acid. There is growing evidence that the observed interaction is caused not by the parent drugs, but by the 4-oxo metabolite of enoxacin, pefloxacin and ciprofloxacin.

Full text

PDF
677

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davies B. I., Maesen F. P., Teengs J. P., Baur C. The quinolones in chronic bronchitis. Pharm Weekbl Sci. 1986 Feb 21;8(1):53–59. doi: 10.1007/BF01975481. [DOI] [PubMed] [Google Scholar]
  2. Davies B. I., Maesen F. P., Teengs J. P. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study. J Antimicrob Chemother. 1984 Sep;14 (Suppl 100):83–89. doi: 10.1093/jac/14.suppl_c.83. [DOI] [PubMed] [Google Scholar]
  3. Grygiel J. J., Miners J. O., Drew R., Birkett D. J. Differential effects of cimetidine on theophylline metabolic pathways. Eur J Clin Pharmacol. 1984;26(3):335–340. doi: 10.1007/BF00548764. [DOI] [PubMed] [Google Scholar]
  4. Hendeles L., Weinberger M., Bighley L. Absolute bioavailability of oral theophylline. Am J Hosp Pharm. 1977 May;34(5):525–527. [PubMed] [Google Scholar]
  5. Koup J. R., Brodsky B. Comparison of homogeneous enzyme immunoassay and high-pressure liquid chromatography for the determination of theophylline concentration in serum. Am Rev Respir Dis. 1978 Jun;117(6):1135–1138. doi: 10.1164/arrd.1978.117.6.1135. [DOI] [PubMed] [Google Scholar]
  6. Vree T. B., Baars A. M., Wijnands W. J. High-performance liquid chromatography and preliminary pharmacokinetics of enoxacin and its 4-oxo metabolite in human plasma, urine and saliva. J Chromatogr. 1985 Oct 11;343(2):449–454. doi: 10.1016/s0378-4347(00)84618-6. [DOI] [PubMed] [Google Scholar]
  7. Wijnands W. J., Vree T. B., Van Herwaarden C. L. Enoxacin decreases the clearance of theophylline in man. Br J Clin Pharmacol. 1985 Dec;20(6):583–588. doi: 10.1111/j.1365-2125.1985.tb05115.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wijnands W. J., van Herwaarden C. L., Vree T. B. Enoxacin raises plasma theophylline concentrations. Lancet. 1984 Jul 14;2(8394):108–109. doi: 10.1016/s0140-6736(84)90283-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES